SOUTH SAN FRANCISCO, Calif. (AP) 鈥� SOUTH SAN FRANCISCO, Calif. (AP) 鈥� Cytokinetics Inc. (CYTK) on Thursday reported a loss of $198.8 million in its second quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.50.
The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.63 per share.
The biopharmaceutical company posted revenue of $28.6 million in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $20.4 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/CYTK
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
